Pacer BioThreat Strategy ETF (VIRS) Research
This exchange-traded fund focuses its investments on U.S.-listed companies that offer products or services aimed at protecting against, enduring, or recovering from biological threats to human health. Its portfolio manager strives to allocate nearly all of the fund's capital to the specific securities that comprise its benchmark index. Notably, this fund operates on a non-diversified basis.
Market snapshot
- Symbol
- VIRS
- Price
- $40.03
- Day change
- +0.03%
- Market cap
- $4.0M
- 52-week range
- 30.3021-40.03
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- Blue Horizon BNE ETF (BNE)
- Unity Wealth Partners Dynamic Capital Appreciation & Options ETF (DCAP)
- Innovator Double Stacker ETF – October (DSOC)
- Harbor Disruptive Innovation ETF (INNO)
- iShares Emergent Food and AgTech Multisector ETF (IVEG)
- Fount Metaverse ETF (MTVR)
- NightShares 500 ETF (NSPY)
- Simplify Nasdaq 100 plus convexity ETF (QQC)
Open Pacer BioThreat Strategy ETF (VIRS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.